State Government Page on Trade Policy and Evidence Based Drug Pricing

• National Legislative Association on Prescription Drug Prices, Brief Overview of Industry/Government Efforts to Undermine Evidence-Based Pricing and Reimbursement Policies, (February 19, 2009). 
• Transcript of Sharon Treat's Remarks on the Panel Achieveing Innovation + Access in Global Pharmaceutical Markets. Washington College of Law, (February 19, 2009).
• ME State Rep. Sharon Treat and AZ State Sen. Meg Burton Cahill, Letter to Stanford Professor John Barton on his proposal for a trade agreement to limit reference pricing of drugs, (May 18, 2009).
• Letter from Ginny Lyons, VT State Senator, and Kathleen Keenan, VT State Representative, to Sens. Patrick Leahy and Bernard Sanders, and Rep. Peter Welsh. (April 18, 2007).
• Letter from Meg Burton Cahill, AZ State Senator, and Kevin Ryan, CT State Representative, to Rep. Sander Levin and the House Ways and Means Subcommittee on Trade, (March 18, 2007).
• Letter from Sharon Treat and Sean Flynn to U.S. Senate Finance Committee on Prescription Drug Price Negotiation (January 11, 2007).